Q3 2026 13F filing
Updated 6 days ago37 disclosed positions worth $1.3B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C Cullinan Therapeutics, Inc. | $149.2M | 9.72M | 11.07% | — |
| 2 | A Aktis Oncology, Inc. | $94.2M | 4.84M | 6.99% | — |
| 3 | T Travere Therapeutics Inc | $64.1M | 1.09M | 4.75% | — |
| 4 | E Edgewise Therapeutics Inc | $64M | 1.58M | 4.75% | — |
| 5 | D Dyne Therapeutics, Inc. | $51.7M | 3.21M | 3.83% | — |
| 6 | C Corcept Therapeutics, Inc. | $48.6M | 422.0K | 3.61% | — |
| 7 | C Corcept Therapeutics, Inc. | $48.6M | 422.0K | 3.61% | — |
| 8 | R Relay Therapeutics Inc. | $42.8M | 2.37M | 3.17% | — |
| 9 | T Trevi Therapeutics Inc | $42.7M | 2.98M | 3.17% | — |
| 10 | J Iovance Biotherapeutics, Inc. | $42M | 2.84M | 3.12% | — |
| 11 | L Liquidia Corporation | $40.6M | 1.34M | 3.01% | — |
| 12 | N Natera Inc | $37.4M | 90.6K | 2.78% | — |
| 13 | U Urogen Pharma Ltd | $37M | 909.7K | 2.74% | — |
| 14 | I Immunocore Holdings plc | $36.4M | 1.20M | 2.70% | — |
| 15 | D DBV Technologies S A | $35.8M | 3.04M | 2.66% | — |
| 16 | T Taysha Gene Therapies, Inc. | $35.4M | 7.26M | 2.62% | — |
| 17 | A Abivax SA | $32.5M | 328.4K | 2.41% | — |
| 18 | V Vir Biotechnology, Inc. | $31.4M | 2.81M | 2.33% | — |
| 19 | A Adlai Nortye Ltd | $31.3M | 1.96M | 2.32% | — |
| 20 | V Verastem, Inc. | $31M | 3.85M | 2.30% | — |
| 21 | Q Uniqure NV | $29M | 1.20M | 2.15% | — |
| 22 | O Odyssey Therapeutics, Inc. | $28.6M | 1.29M | 2.13% | — |
| 23 | T Tarsus Pharmaceuticals Inc | $27.7M | 352.7K | 2.06% | — |
| 24 | P Palvella Therapeutics Inc | $27.3M | 197.6K | 2.02% | — |
| 25 | A Aclaris Therapeutics Inc | $27.2M | 5.18M | 2.02% | — |
| 26 | O Oruka Therapeutics Inc | $25M | 300.0K | 1.85% | — |
| 27 | O Oric Pharmaceuticals Inc | $24.5M | 1.82M | 1.82% | — |
| 28 | S Stoke Therapeutics Inc | $24.1M | 925.1K | 1.78% | — |
| 29 | B Belite Bio Inc | $22.7M | 133.4K | 1.68% | — |
| 30 | N Neurogene, Inc. | $21.5M | 771.8K | 1.59% | — |
| 31 | Z Zura Bio Ltd. | $18.5M | 4.45M | 1.37% | — |
| 32 | A Annexon Inc | $18.1M | 4.29M | 1.35% | — |
| 33 | M Monte Rosa Therapeutics Inc | $13.4M | 1.13M | 1.00% | — |
| 34 | B BIOAGE Labs Inc | $13.2M | 1.86M | 0.98% | — |
| 35 | C Corbus Pharmaceuticals Holdings, Inc. | $11.4M | 1.67M | 0.84% | — |
| 36 | D Bright Minds Biosciences Inc | $9.7M | 195.7K | 0.72% | — |
| 37 | T First Tracks Biotherapeutics Inc | $9M | 254.4K | 0.67% | — |